23 /100
LOW RISK
Score updated May 29, 2026

PLX — Protalix BioTherapeutics, Inc. Dilution Risk Tracker

Track PLX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PLX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PLX.
🔔 Track PLX — Get forecast alerts →

💹 Market Data

Market Cap$169.20M
Shares Outstanding80.57M
Float72.73M
Cash$51.08M
Debt$8.48M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 6.2% shares (2025Q4 vs prior)
84 institutional holders · 15.20M shares
#1 BlackRock, Inc. 3.65M shares
#2 Opaleye Management Inc. 2.48M shares
#3 RENAISSANCE TECHNOLOGIES LLC 1.26M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest5.06M
Days to Cover9.7
% of Float7.0%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track PLX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PLX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PLX
📊 PLX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PLX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.